Remodeling the Model T

A new lineage of T helper cells shakes up an old paradigm.

Written byAndrea Gawrylewski
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

In the classic model of immune system response, naive effector T cells differentiate into two kinds of cells that combat antigens. T helper type 1 (TH1) cells clear intracellular pathogens, while T helper type 2 (TH2) cells control certain parasitic infections. In 2005, Casey Weaver's team at the University of Alabama at Birmingham identified a third class of T helper cell that produces the cytokine interleukin 17 (IL-17) in response to autoimmune tissue injury, which they named TH17 cells.1

Weaver's team was trying to explore the relationship between TH1 and IL-17; IL-17 had been identified years earlier, but its exact role in immune signaling was unclear. By blocking interferon-γ (IFN-γ) - a cytokine essential for the differentiation of TH1 cells from naive T cells - TH1 differentiation was blocked, and instead the team detected the secretion of IL-17. This suggested that IL-17 could not have been produced in the presence ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies